Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
NOVEMBER 2024LIFE SCIENCES REVIEW6The healthcare landscape is evolving rapidly, and at the forefront of this transformation is the rise of Patient Empowerment Platforms (PEPs). These digital platforms are reshaping the way patients interact with healthcare systems, giving them greater control over their health data, medical decisions, and overall wellness journeys. With advancements in technology, data privacy, and personalized care, the latest trends in PEPs are helping to redefine patient-centered care and address some of healthcare's biggest challenges.A significant development in Patient Empowerment Platforms is the shift toward data ownership and transparency. Traditionally, healthcare data has been siloed within hospitals, clinics, or insurance systems, making it difficult for patients to access or control their records. Today, however, there is a strong push for patient-owned data, thanks to advancements in digital health technology and regulatory frameworks like the GDPR in Europe and HIPAA in the U.S. These policies support patients' rights to access and share their data as they see fit, with platforms now enabling users to securely view, download, and share their medical records on demand.By putting data back into the hands of patients, these platforms empower individuals to make informed decisions, pursue second opinions, and even analyze their data trends to prevent or mitigate health issues. For example, some platforms provide interactive tools that allow patients to analyze their blood test results over time or receive predictive insights about potential health risks. This shift is helping to create a more transparent, collaborative healthcare ecosystem where patients and providers can engage as partners in care.In this edition, we have featured Bento Biology Platforms. When the participation burden is too high, patients drop out, significantly increasing trial costs and delaying the company's competitive advantage lies in its ability to expedite clinical trials--the cornerstone of life-changing therapies--by shortening the time to market and lowering the price per patient clinical site visit from $4000 to $400.EDITORIALThe Rise of Patient Empowerment PlatformsCopyright © 2024 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com December - 30 - 2024, Vol 05, Issue - 47 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizerRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsVictor Cruz Clara Matthew
< Page 5 | Page 7 >